The pancreatic cancer clinical research group is formed by researchers in the area of Medical Oncology and aims to provide comprehensive patient care and development in areas of clinical research. In addition, the group actively participates in clinical research with other centers through multicenter observational studies.
The group’s main areas of research include:
- The identification of prognostic and predictive factors of response to chemotherapy treatment to provide precision medicine to improve the selection of patients with pancreatic cancer who would benefit from more intensive cancer treatments.
- Evaluation and follow-up of genetic predisposition to pancreatic cancer and familial risk requiring assessment at the Genetic Counseling Unit.
- The study and analysis of the evolution of patients with localized pancreatic cancer and advanced disease after the therapeutic approach and their quality of life throughout the disease.
Dr. Vilma Pacheco Barcia has a degree in Medicine and Surgery from the Autonomous University of Barcelona (2013). Specialist in Medical Oncology after completing his residency via MIR at the Hospital Universitario La Princesa (2019) completing his training in the area of Digestive with a stay at McGill University Health Centre in the area of Medical Oncology performing clinical and translational research focused on pancreatic cancer and a stay at the Pancreatic Cancer Center (Perlmutter Cancer Center – NYU Langone Health) in the translational research laboratory of pancreatic cancer. FSEOM-Merck “Somos Futuro” Award for the professional career during the residency (2020). D. from the Universidad Autónoma de Madrid for the project entitled “Índice de Respuesta Inflamatoria Sistémica:
Prognostic Factor in Pancreatic Cancer” with a grade of outstanding (2021). Master in Molecular Oncology by CEB (2021).
With extensive experience in the diagnostic and therapeutic approach to patients with pancreatic cancer, a high participation in communications at national and international congresses and publications in international journals, the clinical group aims to provide comprehensive patient care and development in areas of clinical research.